UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 18, 2017 5:00 P.M.
Form:
S-1
CIK:
0001208261
Company Name:
IMMUNE PHARMACEUTICALS INC
File Number:
333-220413